Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Riot Platforms Inc (RIOT) vs Stryker Corporation (SYK) Price & Performance

Riot Platforms IncTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Riot Platforms Inc vs Stryker Corporation — how do they compare? Riot Platforms Inc trades at $16.89 (market cap $6.32B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 16.8× Riot Platforms Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Riot Platforms Inc for 16 Days and Stryker Corporation for 21 Days on average.

RIOTSYK
Market Cap
$6.32B$106.24B
Volume
30,571,7562,982,001
Sector
FinancialsHealth
52-Week High
$28.67$388.35
52-Week Low
$11.83$269.75
Typical Hold Time
16 Days21 Days
Enterprise Value
$6.73B$117.70B
Dividend Yield
—1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Riot Platforms Inc

RIOT stock trades at $16.84, down 9.17% in the past 24 hours amid bearish technical signals. The company shows concerning fundamentals with a net income margin of -196.28% and negative cash flow from operations of -$573 million in 2025. However, analyst sentiment remains overwhelmingly positive with 18 buy ratings and a consensus price target of $31.64, representing 88% upside potential. Recent strategic shifts toward AI data center operations with $9.8 billion in contracted lease revenue through 2048 provide long-term growth catalysts.

The outlook remains polarized between strong analyst optimism and challenging financial performance. Investment opportunity exists in RIOT's strategic pivot to AI infrastructure with secured long-term revenue streams, but substantial execution risks persist given current profitability challenges and negative cash flow generation. Stock investors face volatility from both Bitcoin price sensitivity and the company's transition to new business models.

Stryker Corporation

Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.

Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RIOT
19% Buy81% Sell
Avg holding period · 16 Days
SYK

No sentiment data available yet.

Top news

Latest headlines on both assets

About Riot Platforms Inc

Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.

Read more on RIOT →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →